Endometrial Ablation Devices Market Size (2024 - 2029)

Endometrial Ablation Devices Market Analysis

The endometrial ablation devices market studied was projected to grow at a CAGR of 5.2% over the forecast period.

During the COVID-19 outbreak, all outpatient treatments were postponed or restricted to reduce the risk of viral transmission, as most chronic therapies were deemed elective. As per the article published in the Springer Journal in September 2022, during the COVID-19 pandemic, the number of treatments for endometriosis patients was reduced, especially during the first lockdown (March 2020 to May 2020). There was a 37% reduction in the endometriosis outpatient department and a 90% reduction in surgical endometriosis. Thus, the decline in endometrial consultations and surgical procedures during COVID-19 significantly impacted market growth during the initial stages of the pandemic. However, owing to the resumption of endometrial surgeries after the relaxation of strict lockdown regulations during the post-pandemic period, the market is expected to grow over the forecast period.

The major factor attributing to the growth of the market is the increase in the prevalence of gynecological disorders in women, like cervical cancer, menorrhagia, abnormal vaginal bleeding, and PCOD, or polycystic ovarian disease. According to the article published in Elsevier in June 2021, overall, 116 million women were affected by polycystic ovarian syndrome across the world. Additionally, in the study published in the HPV Information Center in October 2021, every year, 351,720 women were diagnosed with cervical cancer in Asia. The report also estimated that a population of 1766.41 million women aged 15 years and older were at risk of developing cervical cancer in Asia. Thus, the growing prevalence of various gynecological diseases is expected to drive demand for endometrial ablation devices owing to the effective treatment, thereby boosting market growth over the forecast period. The increasing number of product launches by various key market players in order to meet the growing demand for endometrial ablation devices is also expected to fuel the market's growth during the forecast period. For instance, in November 2021, Hologic, Inc., launched the NovaSure V5 global endometrial ablation (GEA) device at the 50th Global Congress of the American Association of Gynecologic Laparoscopists (AAGL) in the United States.

Thus, the above-mentioned factors, such as an increase in the prevalence of gynecological disorders and frequent product launches by various market players, are expected to contribute to the growth of the market. However, stringent regulatory policies are expected to impede the growth of the market over the forecast period.

Endometrial Ablation Devices Industry Segmentation

As per the scope of the report, endometrial ablation is a procedure that surgically destroys the lining of the uterus. The goal of endometrial ablation is to reduce menstrual flow; in some women, the menstrual flow stops completely. The endometrial ablation devices market is segmented by device type (hysteroscopy devices, thermal balloon ablators, radiofrequency endometrial ablation devices, hydrothermal ablators, electrical ablators, others), end-user (ambulatory surgical centers, hospitals, clinics), and geography (North America, Europe, Asia-Pacific, the Middle East, Africa, and South America). The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.